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Fruit is a key component of a healthy diet. However, it is still not clear whether some classes of fruit may be more
beneficial than others and whether all individuals whatever their age, gender, health status, genotype, or gut
microbiota composition respond in the same way to fruit consumption. Such questions require further
observational and intervention studies in which the intake of a specific fruit can be precisely assessed at the
population and individual levels. Within the Food Biomarker Alliance Project (FoodBAll Project) under the Joint
Programming Initiative “A Healthy Diet for a Healthy Life”, an ambitious action was undertaken aiming at reviewing
existent literature in a systematic way to identify validated and promising biomarkers of intake for all major food
groups, including fruits. This paper belongs to a series of reviews following the same BFIRev protocol and is
focusing on biomarkers of pome and stone fruit intake. Selected candidate biomarkers extracted from the literature
search went through a validation process specifically developed for food intake biomarkers.
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Introduction
Fruit is an essential component of a healthy diet. In a
comparative risk assessment of global disease burden at-
tributable to 67 risk factors, diets low in fruit were esti-
mated to account for 30% of ischemic heart disease
disability-adjusted life years worldwide and ranked
among the five leading risk factors and as the first diet-
ary factor for global disease burden and mortality [1].
Large prospective cohort studies, increasingly supported
by well-designed randomized clinical trials, have conclu-
sively established the protective effects of high fruit in-
take regarding hypertension, cardiovascular disease, and
stroke, with some evidence of a dose-response relation-
ship [2–5]. High intake of fruit and vegetables (F&V)
have also been associated with prevention of other
chronic diseases such as several cancer types, obesity
and type 2 diabetes, or neurodegenerative diseases, how-
ever, mixed results were reported, and the overall* Correspondence: claudine.manach@inra.fr
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(http://creativecommons.org/publicdomain/zeevidence is more limited [6–9]. There is a strong need
for more research in the field to answer important pend-
ing questions and guide the development of more effi-
cient public health policies and healthy food production.
One major interrogation is whether the total quantity of
fruit consumed is the most important factor or whether
the intake of particular fruits or groups of fruit, or a high
diversity, matters. Some fruits expected to provide im-
portant amount of specific bioactive compounds in the
human diet, such as pomegranate, orange, or cranberry,
have received much interest in the last decades. Due to
the diversity of fruit composition regarding bioactives, it
is important to evaluate the specific health effects of the
individual fruits, to identify their protective constituents
and biological targets and eventually to determine the
most beneficial associations. This is particularly relevant
for the cancer-protective or the anti-obesity effects of
fruit, which were observed to differ for various types of
fruit [6, 10]. Another question concerns the
inter-individual variability in response to fruit consump-
tion. It is not clear whether everyone, regardless of age,
gender, lifestyle, gut microbiota composition, or geno-
type, responds similarly to fruit consumption and if
there is a risk associated with high fruit intake for somele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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tions in human intervention and large prospective stud-
ies in which an accurate assessment of fruit intake can
be made for every subject, not only of total intake of
fruit but also for the intake of several classes of fruit and
individual fruits.
Fruit intake is traditionally assessed with dietary ques-
tionnaires. The usual consumption of total F&V is some-
times the only information inquired in Food Frequency
Questionnaires (FFQs), and even in the most detailed
FFQs classes of fruit (such as pome, citrus, drupes, ber-
ries, nuts….) may be distinguished, but rarely individual
species (apples, pears, oranges, grapefruits, etc.) and al-
most never down to the variety. Repeated 24-h recalls
are more precise but still biased by self-reporting in-
accuracy. The consumption of fruit and vegetables has
been shown to be particularly prone to overestimation
in dietary questionnaires, at least for a fraction of the
population [11]. Complementary to questionnaires, bio-
markers such as plasma vitamin C and plasma caroten-
oids have been widely used [5, 12]. However, as shown
in a systematic review and meta-analysis of 19 interven-
tion studies, these biomarkers can reflect group-level dif-
ferences for assessing compliance to F&V interventions,
but are not accurate enough to precisely reflect
individual-level intakes [13]. These traditional bio-
markers give heterogeneous responses depending on the
type of F&V consumed and are affected by a range of in-
trinsic and environmental factors.
The Food Biomarker Alliance (FoodBAll), a project
funded by the Joint Programming Initiative, “A Healthy
Diet for a Healthy Life” (http://www.healthydietfor
healthylife.eu/), has undertaken a systematic evaluation
of traditional and newly discovered biomarkers of food
intake (BFIs). Guidelines were established for conducting
a systematic literature search dedicated to food intake
biomarkers [14] and for evaluating their level of valid-
ation using a set of consensus criteria [15]. The guide-
lines were applied for more than 140 foods from all
major food groups: fruit and vegetables, meats, fish and
other marine foods, dairy products, cereals and whole-
grains, alcoholic and non-alcoholic beverages, vegetable
oils, nuts, and spices and herbs (http://foodmetabolom
e.org/wp3). The present article presents the results of
the in-depth exploration of possible biomarkers of intake
for important classes of fruit, the pome and stone fruit.
Methods
Selection of food groups
The most widely consumed pome and stone fruit were
inventoried [16]. For pome fruit, the apple (Malus
domestica Borkh.) and pear (Pyrus communis L.) were
selected, as well as quince (Cydonia oblonga Miller),
which is less frequently consumed as jams, marmalade,jellies, or “pâte de fruit.” For stone fruit, sweet cherry (Pru-
nus avium L.), sour cherry (Prunus cerasus L.), plum and
prune (Prunus domestica L.), apricot (Prunus armeniaca
L.), peach (Prunus persica (L.) Batsch), and nectarine (Pru-
nus persica var. nucipersica (Borkh.) C.K.Schneid.) were
covered. Botanical genus and generic fruit group names
were also used in the search, as described below, to ensure
that no other important pome or stone fruits were missed.
Search for relevant BFI research papers
An extensive literature search was carried out to collect
all available information on the existing and new candi-
date BFIs for the selected fruits. The BFIRev protocol
(Food Intake Biomarker Reviews) described previously
was followed [14]. Briefly, a primary search was per-
formed in three databases, Scopus, PubMed central, and
Web of Science with the name of the specific fruit and
its botanical genus, i.e., (pear OR pyrus*), (apple* OR
Malus domestica), (quince OR Cydonia oblonga), and
(plum OR peach OR nectarine OR cherry OR apricot
OR prunus OR drupe* OR stone fruit) along with the
common keywords: AND (urine OR plasma OR serum
OR excretion OR blood) AND (human* OR men OR
women OR patient* OR volunteer* OR participant*)
AND (biomarker* OR marker* OR metabolite* OR bio-
kinetics OR biotransformation OR pharmacokinetics OR
bioavailability OR ADME) AND (intake OR meal OR
diet OR ingestion OR administration OR consumption
OR eating OR drink*). Keywords were used in the fields
[Topic], [All fields], and [Article Title/Abstract/Key-
words] for Web of Science, PubMed, and Scopus, re-
spectively. All searches were carried out in March 2016
and updated in May 2017. Only papers in English lan-
guage were considered eligible, and no restriction on the
date of publication was applied. Articles showing results
of human intervention studies (randomized controlled
trials, acute, short-term or long-term studies) or obser-
vational studies (cohort, case-control, cross-sectional
studies) were considered eligible. After duplicate re-
moval, a first selection of papers was performed accord-
ing to relevance of abstract and title. Full texts were
obtained for the selected articles and further assessed for
eligibility according to their relevance in determining
BFIs for pome and stone fruit. Some of the publications
found in the reference list of the selected articles were
also included at this stage.
The process of selection of the articles identifying or
using potential biomarkers of intake is outlined in Fig. 1.
Identification and characterization of candidate BFIs
For each potential biomarker identified, a secondary
search allowed to retrieve relevant information to assess
the quality of the individual biomarkers, regarding their
specificity, their pharmacokinetics, dose-response
Fig. 1 Flow diagram of study selection according to the BFIRev procedure
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method of analysis, in order to qualify their use as BFIs
according to the validating scheme established by
Dragsted et al. [15].
The name of the potential biomarkers and their syno-
nyms were queried in the previously mentioned data-
bases along with AND (biomarker* OR marker* OR
metabolite* OR biokinetics OR biotransformation OR
pharmacokinetics OR bioavailability OR ADME). Add-
itionally, the compounds were searched manually in the
online databases, HMDB (https://www.hmdb.ca), FooDB
(http://foodb.ca/), Phenol-Explorer (http://phenol-ex
plorer.eu/), Dictionary of Food Compounds (http://
dfc.chemnetbase.com/faces/chemical/ChemicalSearch.xh
tml), Duke’s phytochemical and ethnobotanical data-
bases (https://phytochem.nal.usda.gov/phytochem/sea
rch), eBASIS (http://ebasis.eurofir.org/Default.asp),
Knapsack (http://kanaya.naist.jp/knapsack_jsp/top.html),
and PhytoHub (http://phytohub.eu) to determine all the
possible dietary or metabolic origins of the candidate BFIs.
Specific and non-specific biomarkers were discussed in
the text, while only the most plausible candidate BFIs
for pome fruit have been reported in Table 1 along with
the information related to study designs and analytical
methods. The non-retained compounds for pome fruit
and stone fruit are listed in Tables 2 and 3, respectively,
along with the main reasons for exclusion and with the
corresponding references for an exhaustive presentationof the results. The tables have been reviewed and agreed
upon by all authors and no additional markers were
suggested.
Application of validation criteria
According to Dragsted et al., a set of validation criteria
was applied to the candidate BFIs reported in Table 1, in
order to assess their current status of validation and to
identify the missing information for a full validation of
each of them [15]. The validation scheme is based on
eight questions related to the analytical and biological
aspects: Q1: Is the marker compound plausible as a spe-
cific BFI for the food or food group (chemical/biological
plausibility)? Q2: Is there a dose-response relationship at
relevant intake levels of the targeted food (quantitative
aspect)? Q3: Is the biomarker kinetics described ad-
equately to make a wise choice of sample type, fre-
quency, and time window (time-response)? Q4: Has the
marker been shown to be robust after intake of complex
meals reflecting dietary habits of the targeted population
(robustness)? Q5: Has the marker been shown to com-
pare well with other markers or questionnaire data for
the same food/food group (reliability)? Q6: Is the marker
chemically and biologically stable during biospecimen
collection and storage, making measurements reliable
and feasible (stability)? Q7: Are analytical variability
(CV%), accuracy, sensitivity, and specificity known as ad-
equate for at least one reported analytical method
Table 1 List of studies reporting candidate biomarkers for pome fruit consumption
Dietary factor Study design Number of
subjects
Analytical
method
Biofluid Discriminating metabolites/
candidate biomarkers
Primary
reference(s)
Apple
Apple
(24-h recalls,
58.7 ± 113.5 g/day+)
Observational study 53
(31 women, 22 men)
HPLC-MS Urine
(spot and 24 h)
• Phloretin
• Other non-specific
polyphenol
metabolites
[40]
Apple
(FFQ and food diaries,
47 (3–140)g/day*)
Observational study 119 (all women) HPLC-ESI-MS Urine
(24 h)
Plasma
• Phloretin
• Other non-specific
compound
[42]
Apple (24-h recall,
61 (0–317) g/day*)
Observational study:
5 months of free
access to fruit
basket in
working place.
79 HPLC-ESI-MS Urine
(24 h)
• Phloretin
• Other polyphenols
for other fruits
[41]
Apple and pear
(24-h recalls,
228 ± 239 g/day+)
Observational study 481 Untargeted
HPLC-TOF-MS
Urine
(24 h)
• Phloretin
glucuronide
• Other non-specific
epicatechin
metabolites
[17]
40 g of lyophilized
apples:
polyphenol-rich
vs polyphenol-poor
apples
Double-blind,
randomized
cross-over trial,
4-week periods
30 (all men) LC-MS Morning spot urine • Phloretin [47]
25 g of unripe
apple processed
in powder
Randomized
cross-over study
(two 1-day
interventions: (1)
50 g OGTT and (2)
50 g OGTT+ 25 g
apple powder)
6 (all women) LC-MS Urine
(0 h, 0-2 h, 2–4 h)
• Phloretin
• Phloretin
glucuronide
[45]
1 L cloudy apple juice Kinetics
intervention,
single dose
11
(healthy ileostomy
subjects)
HPLC-DAD;
HPLC-ESI-MS/MS
Ileostomy fluid
(0 h, 1 h, 2 h, 4 h,
6 h, and 8 h)
• Phloretin
2′-O-xyloglucoside
• Phloretin
2′-O-glucuronide
• Phloretin
• Other non-specific
polyphenol
metabolites
[46]
0.7 L of apple
smoothie
Single dose,
kinetic study
10
(healthy
ileostomy
persons)
HPLC-DAD and
HPLC-MS/MS
Ileostomy fluid
(0 h, 1 h, 2 h, 4 h,
6 h, and 8 h)
• Phloretin 2′-O-
xyloglucoside
• Phloretin 2′-O-
glucuronide
(and isomers)
• Phloretin
• Other non-specific
polyphenol
metabolites
[95]
1 kg of apple
(organic vs
conventional)
Randomized,
cross-over
single-dose study
(2 experimental
days, 1 per
intervention)
6 (all men) HPLC-MS Plasma
(0 h, 1 h, 2 h, 3 h,
4 h, 5 h, 6 h, 9 h,
12 h, 24 h)
• Phloretin [43]
500 g/day apple for
4 weeks (organic
vs conventional
vs no apple)
Double-blind,
randomized
parallel study (3
interventions: (1)
organic apple, (2)
conventional apple,
(3) control)
43 (all men) HPLC-MS Plasma
(day 0 and day
28 24 h after last
intake of fruit)
• Phloretin [43]
Apple
(low: 200 ± 10 g,
medium: 400 ± 10 g
and high: 790 ± 10 g
consumption)
Acute parallel study
with three groups
30
(14 women,
16 men)
HPLC-ESI-QTrap Urine
(0 h, 0–2 h, 2–4 h,
4–6 h, 6–8 h,
8–10 h, 10–12 h,
12–14 h, 14–16 h,
48 h morning spot,
72 h morning spot,
• Phloretin
• Other non-specific
polyphenol
metabolites
[48]
Ulaszewska et al. Genes & Nutrition           (2018) 13:29 Page 4 of 16
Table 1 List of studies reporting candidate biomarkers for pome fruit consumption (Continued)
Dietary factor Study design Number of
subjects
Analytical
method
Biofluid Discriminating metabolites/
candidate biomarkers
Primary
reference(s)
96 h morning spot)
Pear
Pear (0.6 g/kg/h)
vs Banana (0.6 g/kg/h)
vs water (3 ml/kg/h)
Cross-over,
randomized
controlled trial
(3 experimental
days, 1 per
intervention)
20 (all men) Untargeted
UPLC-QTOF-MS
Plasma
(T0, immediately after
cycling, 1.5 h after
cycling trial and
21-h post exercise)
• Arbutin
• Hydroquinone
sulfate
• Other non-specific
compounds
(sugars, polyphenol
microbial
metabolites)
[64]
Pear (1 fruit, as part
of a high Hydroquinone
diet)
Controlled
Intervention study
(3 experimental
days, 1 per
intervention: high
hydroquinone meal
with pear, low
hydroquinone and
acetaminophen)
4 (2 women, 2 men) GC-ED Plasma
(30, 60,
120 min after meal)
Urine
(2-h interval collection in
a 8-h period after meal)
• Conjugated
hydroquinone
[65]
Abbreviations: OGTT oral glucose tolerance test, HPLC-MS high-performance liquid chromatography-mass spectrometry, HPLC-ESI-MS high-performance
liquid chromatography-electron spray ionization-mass spectrometry, HPLC-TOF-MS high-performance liquid chromatography-time-of-flight-mass
spectrometry, LC-MS liquid chromatography-mass spectrometry, HPLC-DAD high-performance liquid chromatography-with diode-array-detection, UPLC-
QTOF-MS ultra-performance liquid chromatography-quadrupole-time-of-flight-mass spectrometry, GC-ED gas chromatography-electron capture detector
+Data reported in mean and SD
*Data reported in medians and percentiles
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cessfully reproduced in another laboratory (reproducibil-
ity)? Possible answers to each of mentioned questions
were Yes, No or Unknown (Y/N/U), where “unknown”
indicates lack of information in the literature. The
current validation status of the candidate BFIs has been
reported in Fig. 2.
Results
Pome fruit
The literature search for biomarkers of apple intake re-
sulted in 324 citations among which 46 articles were
retained for full-text evaluation after screening of titles
and abstracts, and 14 papers were finally selected after
careful consideration of the inclusion criteria. Figure 1
shows a full flowchart with inclusion and exclusion cri-
teria, and number of peer-reviewed papers in each part
of evaluation. The main exclusion criteria were papers
that discussed the effect of the intake of the different
fruits on physiology, immunology, on diverse patholo-
gies, or on drug metabolism, and animal or in vitro stud-
ies with unfitting design. Five observational studies,
seven single-dose studies and two 4-week intervention
studies reported associations between apple intake and
plasma, urine or ileostomy fluid concentration of apple
metabolites, which may represent candidate BFIs. A
large majority of the selected articles described studies
that aimed at quantifying polyphenol metabolites after
apple intake and were motivated by an interest in the
health effects of these bioactives. Two investigationsused an untargeted metabolomics approach in cohort
studies with the objective to identify the strongest asso-
ciations between consumption of various food groups
assessed by dietary questionnaires and metabolites iden-
tified in blood or urine metabolomes [17, 18]. A descrip-
tion of all studies reporting associations between apple
intake and the most promising candidate BFIs for apple
is given in Table 1. Four studies were not included in
this table. Rago et al. [19] explored the effects of apple
products consumption on the plasma metabolome but
only reported changes in endogenous compounds, thus
this article was not retained. Two studies, reported
increased plasma concentration or urinary excretion of
epicatechin after consumption of apple products [20, 21].
However, epicatechin has several other major dietary
sources such as cocoa, tea, and other fruits (berries, apri-
cots, grapes) [22–24] and is not specific enough to repre-
sent a candidate BFI for apple. In the fourth study,
Pallister et al. [18] applied a metabolomics approach on
3500 fasting blood samples in a large twin cohort. Among
the most significant associations observed were those be-
tween apple and pear intake and plasma threitol
(0.033[0.003]; P = 1.69 × 10−21), indolepropionate
(0.026[0.004]; P = 2.39 × 10−9), and 3-phenylpropionate
(0.024[0.004]; P = 1.24 × 10−8). However, many con-
founders might explain these associations. Furthermore,
the microbial metabolite 3-phenylpropionate is a
non-specific degradation product of polyphenols such as
naringin, ferulic acid, or proanthocyanidins [25]. Indole-
propionate is a tryptophan metabolite produced by the
Table 2 List of non-retained compounds for pome fruit
Food item Compound PhytoHub ID HMDB ID Biofluid Reasons for exclusion References
Apple Dihydroxyphenyl-γ-
valerolactone,
dihydroxyphenyl-γ-
valerolactone sulfate
PHUB001060 - HMDB0029185
-
Urine Non-specific flavanol metabolite,
common for many fruits
and vegetables,
too variable background
[17, 28]
Apple D-(-)-quinic acid PHUB000633 HMDB0003072 Ileostomy fluid,
plasma, urine
Non-specific, common for
many fruits,
[18, 40, 43,
46, 95]
Apple p-Coumaric acid,
hydroxycinnamic acid,
methyl caffeic acid,
methyl p-coumarate
PHUB000590
PHUB000588
-
PHUB001887
HMDB0030677,
-
-
-
Ileostomy fluid,
plasma, urine
Non-specific, common for
many fruits,
[18, 40, 43,
46, 95]
Apple 1-Caffeoylquinic acid,
3-caffeoylquinic acid,
4-caffeoylquinic acid,
5-caffeoylquinic acid,
3-p-coumaroylquinic acid,
4-p-coumaroylquinic acid,
5-p-coumaroylquinic acid,
PHUB000514
PHUB000530
PHUB000537
PHUB000585
PHUB000534
PHUB000545
PHUB000558
HMDB0030652,
HMDB0003164
HMDB0040690,
HMDB0030653,
HMDB0029681,
-
-
Ileostomy fluid Non-specific, common for many
fruits and vegetables,
lack in plasma and urine
[46, 95]
Apple Catechin,
epicatechin,
(epi)catechin-O-sulfate,
oligomeric procyanidins,
procyanidin B2,
procyanidin B5
PHUB000261
PHUB001241
PHUB001040
-
PHUB000277
PHUB000280
HMDB0002780,
HMDB0001871,
HMDB0012467
-
HMDB0033973,
HMDB0038366
Ileostomy fluid,
plasma, urine
Non-specific, common for
many fruits
[17, 20, 21,
46, 95]
Apple Quercetin,
kaempferol,
isorhamnetin,
quercetin 3-O-arabinoside,
quercetin 3-O-rhamnoside,
quercetin 3-O-glucoside,
quercetin 3-O-galactoside,
quercetin 3-O-xyloside
PHUB000702
PHUB000672
PHUB000662
PHUB000654
PHUB001763
PHUB000661
PHUB001454
PHUB000716
HMDB0005794,
HMDB0005801,
HMDB0002655,
HMDB0033795,
HMDB0033751,
HMDB0037362,
HMDB0030775,
HMDB0037927,
Ileostomy fluid,
urine
Non-specific, common for
many fruits.
Glycosides expected only
in ileostomy fluid
[40, 41, 46,
48, 95]
Apples and pears Threitol – HMDB0004136 Plasma Alcohol-sugar present in many
fruit and fermented foods
[18]
Apples and pears Indolepropionate – HMDB0002302 Plasma Microbial metabolite of tryptophan [18]
Apples and pears 3-Phenylpropionate PHUB001078 HMDB0000764 Plasma Non-specific microbial metabolite
of polyphenols
[18]
Pear Sugars: xylose,
fructose,
ribitol,
mannitol,
sorbitol,
arabitol,
xylitol
– HMDB00098;
HMDB00660;
HMDB00508;
HMDB00765;
HMDB00247;
HMDB00568;
HMDB02917
Plasma Non-specific sugars and alcohol sugars;
found in many fruits and other foods
[64]
Pear Eugenol sulfate PHUB001888 – Plasma Metabolite of eugenol present
in several fruits. Non-specific
metabolite
[64]
Pear 2-Isopropylmalate – HMDB00402 Plasma Non-specific, scarce information
on kinetics and dose-response
[64]
Pear Vanillic alcohol sulfate – – Plasma Metabolite of vanillic acid, which is
found in fruit; scarce information
on kinetics and dose-response
[64]
Pear 3-(4-Hydroxyphenyl) propionate;
4-hydroxyhippurate;
hippuric acid
PHUB001177
PHUB001334
PHUB001174
HMDB02199;
HMDB13678;
HMDB00714
Plasma Metabolites of phenolic acids and
other polyphenols; scarce information
on kinetics and dose-response
[64]
Pear 4-Allylphenol sulfate PHUB001891 – Plasma Metabolite of 4-allyphenol found in
essential oils and several fruits.
Non-specific compound
[64]
Abbreviations: HMDB ID human metabolome database identification number, http://www.hmdb.ca; PhytoHub ID (http://phytohub.eu/)
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has been shown so far. Threitol is a sugar alcohol-like
erythritol occurring naturally in many fruits andfermented foods. None of these three compounds was
thus considered to be specific for apple consumption and
the study was also excluded from Table 1. From the ten
Table 3 List of non-retained compounds for stone fruit
Food item Compound PhytoHub ID HMDB ID Biofluid Reasons for exclusion References
Cherry Cyanidin 3-rutoside,
cyanidin 3-O-glucoside,
cyanidin-3-glucosylrutinoside
PHUB000504
PHUB000503
PHUB001606
HMDB0031458
HMDB0030684
HMDB0037988
Plasma, urine Common to many anthocyanin-rich foods;
very low concentrations even after
acute intake; very transient increase (< 2 h)
[79]
Cherry 6-Sulfatoxymelatonin PHUB001884 HMDB0041815 Urine Main metabolite of melatonin; common
to all melatonin-rich foods.
Also endogenous origin, affected by
many factors (age, BMI, smoking…)
[84, 85]
Cherry 5-Hydroxyindoleacetic acid PHUB001475 HMDB00763 Urine Main metabolite of serotonin; common
to all serotonin-containing foods such
as banana, pineapple, and walnut;
also endogenous origin
[88]
Plum Anthocyanins:
peonidin 3-glucoside,
peonidin 3-rutoside,
cyanidin monoglucuronide
PHUB001257;
PHUB001296;
HMDB13689 Urine Present in other berries, drupes,
and red wine.
Very low concentration
and short half-life
[96]
Plum Hippuric acid PHUB001174 HMDB00714 Urine Very common metabolite of polyphenols
with many possible origins; not specific
[96]
Plum Caffeic acid PHUB000574 HMDB01964 Plasma, urine Widely distributed in plant foods;
not specific
[92]
Plum 5-Hydroxymethyl-2-furoic acid,
(5-carboxylic acid-2-furoyl)glycine
PHUB001892
PHUB001894
– Plasma, urine Metabolites of 5-hydroxymethylfurfural
(HMF), also present in coffee, dried fruit,
fruit juices and honey
[93]
Cherry Hydroxycinnamic acids:
caffeic acid,
ferulic acid,
p-coumaric acid, vanillic acid
PHUB000574
PHUB000608
PHUB000316
HMDB0001964
HMDB0000954
HMDB0000484
Plasma Widely distributed in plant foods;
not specific
[97]
Abbreviations: HMDB ID human metabolome database identification number, http://www.hmdb.ca; PhytoHub ID: http://phytohub.eu/
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most likely, the major metabolites of the apple dihydro-
chalcones phloridzin and phloretin 2′-O-xyloglucoside,
were the only compounds consistently reported and finally
retained for further evaluation as candidate BFIs for apple
[26, 27]. An inventory of all the compounds observed after
apple consumption but not retained as candidate BFIs is
given in Table 2 with the main reasons for exclusion and
original references. As the available data were quite lim-
ited, we also considered two investigations in rats fed ap-
ples during several weeks, as they used an untargeted
mass spectrometry-based metabolomics approach likely to
reveal new candidate biomarkers of intake that could be
further studied in humans [28, 29]. Rago et al. [29] com-
pared the plasma metabolomes of rats fed a control diet
or the same diet supplemented with fresh apple slices.
They found amino acids, carnitines, and lysophosphocho-
lines as most discriminant metabolites, rather reflecting
metabolic effects of apple than exposure to its compo-
nents. Kristensen and coworkers [28] observed quinic acid,
coumaric acid, epicatechin glucuronide, catechin glucuro-
nide, methyl epicatechin, dihydroxyphenyl-valerolactone,
hippuric acid, hydroxyhippuric acid, and homovanillic acid
sulfate among the metabolites elevated in urine after apple
intake. None of these can be considered as specific for ap-
ples. However, the authors shared a list of non-identified
markers that increased significantly in all 24 animals afterapple intake and not in the other group (7% apple pectins).
These markers if found again discriminant in other meta-
bolomics studies may deserve further identification work
to provide specific biomarkers of apple intake, in comple-
ment to phloretin in urine.
Much less studies have been found for the other pome
fruit pear and quince. Of the 338 papers retrieved from
the primary literature search, 12 were eligible. After fur-
ther assessment, only two papers were finally selected as
relevant for pear BFIs (Table 1) while for quince no art-
icle was retained. Based on this very limited information,
the only compounds that were retained as possible BFIs
for pear were arbutin and hydroquinone sulfate. As for
apple, some compounds listed in Table 2 were described
in biofluids after pear intake but, for various reasons
mostly related to a lack of specificity, were ruled out as
candidate BFIs.
For the four candidate BFIs retained for apple and
pear, validation criteria were examined and reported in
Fig. 2 and further discussed below.
Stone fruit
A total of 433 references were screened for stone fruit,
of which 11 original papers fulfilling the criteria were
carefully examined, but none of them aimed at identify-
ing biomarkers of intake. Of the retained references,
seven described studies on cherry, including one
Fig. 2 Scheme of literature evaluation process for pome fruits with BFIs: phloretin, phloretin glucuronide, and arbutin
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4-week intervention studies. Six studies, all small size
(involving 2 to 6 volunteers), focused on plum or prune.
There was no data in the literature on potential BFIs for
peach, nectarine, or apricot. No observational studies
were published for stone fruit. Finally, no candidate BIF
could be identified, even for cherry or plum from the lit-
erature survey. Table 3 lists all the metabolites reported
to be associated with stone fruit intake but not retained
as candidate BFIs, and the reasons for their exclusion
are discussed below.
Of note, no biomarkers for the pome fruit and stone
fruit as food groups emerged from the systematic search.
Discussion
Apple biomarkers
Apple (Malus domestica) is the most consumed fruit in
Europe [16], and one of most popular fruits worldwide
[30, 31]. It represents the icon of healthy foods and hasbeen suggested to exert protective effects towards CVD
and other diseases [32–38]. Having a BFI for apple
would be extremely useful to further document the ef-
fect of this healthy food, as well as for assessing dietary
patterns of individuals, when used as part of a panel of
BFIs covering major food groups. The nutrient compos-
ition of apples is well known [39]. Its most characteristic
secondary metabolites are phloridzin (phloretin
2′-O-glucoside) and phloretin 2′-O-xyloglucoside, while
other polyphenols such as epicatechin, proanthocyani-
dins, and chlorogenic acid are prevalent but common to
many other food sources (e.g., other fruits such as ber-
ries, or green and black tea, coffee). Four observational
studies have reported associations between phloretin
and its derivatives and apple intake. Mennen et al. [40]
searched correlations between the urine concentration
of 13 polyphenols and the consumption of
polyphenol-rich foods including apple, in the French
SUVIMAX cohort study. They reported that apple
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significantly correlated (r = 0.6, P < 0.0001) with phlore-
tin concentration in morning spot urine and, to a lesser
extent, with m-coumaric acid, isorhamnetin, kaempferol,
and phloretin in 24-h urine samples [40]. Of these com-
pounds, only phloretin can be considered as specific to
apple. Kaempferol is present in many leaf vegetables,
herbs, beans, and berries, m-coumaric acid is found in
high content in olive, while isorhamnetin is a human
metabolite of the widely distributed flavonol, quercetin
[22–24]. A mean apple intake of 239.2 ± 95.0 g/day cor-
responded to a phloretin excretion of 0.73 ± 1.9 μmol/d
and 0.42 ± 0.5 μmol/L in 24 h and spot urine, respect-
ively [40]. Similar correlations were found between apple
intake and phloretin urinary excretion in three observa-
tional studies by Krogholm et al. (79 volunteers) [41],
Brantsæter et al. (119 volunteers) [42], and Edmands
et al. (481 volunteers) [17]. Food intake was assessed
with FFQ and 24-h recalls, while 24-h urine was
analyzed with untargeted [17] or targeted approaches
[41, 42]. Urinary excretion of phloretin (Krogholm et al.:
r = 0.22, p < 0.01; Brantsæter et al., 2007: r = 0.25, p < 0.05)
and phloretin glucuronide (AUC ROC curve = 75.8%,
Edmands et al.) were found to be significantly correlated
with “apple and pear” intake, but also with overall intake
of fruit [17, 41, 42]. It can be speculated that among the
population declaring a high consumption of fruit and
fruit-based products, apples are particularly popular.
Edmands et al. [17] also reported urine dihydroxyphenyl
-γ-valerolactone sulfate and methyl(epi)catechin sulfate,
two metabolites of epicatechin, to be correlated with
apple and pear intake in addition to phloretin, but as
discussed previously epicatechin is present in too
many other food sources.
Some pharmacokinetics data are available for phloretin
after consumption of apple or apple products in inter-
vention studies. Phloretin was generally found at very
low concentrations or below the limit of detection in
plasma in the form of phloretin [43] or phloretin 2′-glu-
curonide [44, 45]. After consumption of 1 kg apples
(Golden Delicious cultivar), the maximum phloretin
concentration measured in men after enzymatic hydroly-
sis of plasma conjugates was 12.1 ± 6.6 nmol/L, with a
Tmax in the range of 2.8–3.2 h [43]. Phloretin plasma
Cmax and Tmax reported after cider and apple juice intake
were in the same order of magnitude, although slightly
higher than those after apple fruit intake: 73 ± 11 nmol/L
and 0.6 ± 0.1 h after ingestion of 500mL apple cider (nine
subjects) [26] and 170 ± 90 nmol/L and 2.1 ± 0.5 h after in-
take of 1 L cloudy apple juice by five subjects [46]. Stracke
and coworkers [43] reported that phloretin concentration
was not increased in fasting plasma collected 24 h after the
last intake of a 4-week supplementation period with 500 g
apples per day in 43 men [43]. These data suggest that thehalf-life of phloretin is too short to allow accumulation in
plasma. Furthermore, the maximum concentration reached
in plasma after high intake of apple is very low (nmol/L
range) suggesting that phloretin would be difficult to quan-
tify for low to moderate apple intakes. The study by Rago
et al. [19] is consistent with these data. Neither phloretin
nor its metabolites were found among the discrimin-
ating markers in fasting plasma metabolomes of 24
volunteers after 4 weeks of supplementation with
whole apples (550 g/day), clear and cloudy apple
juices (500 ml/day), or dried apple pomace (22 g/day)
compared to a non-supplemented diet [19].
Phloretin urinary excretion may be more useful to reflect
the intake of apple and apple products. Phloretin is exclu-
sively present in urine in conjugated forms, with a large
predominance of phloretin-2′-O-glucuronide [26, 46].
After consumption of a single dose of 1 L cloudy apple
juice, 0.54 μmol phloretin were measured in hydrolyzed 24
h urine, with 87% excreted in the 0–12-h period [46].
Compared to cloudy juice, phloretin excretion was shown
higher after cider intake. After a 500ml apple cider dose,
Marks et al. [26], reported a phloretin excretion of 2.3 μmol
in 24 h, with 98% of the dose excreted in the 0–8-h period
in nine volunteers. Similarly, the urinary excretion of
phloretin reached 3.8 ± 1.0 μmol in 24 h after 1.1 L apple
cider [44]. Auclair et al. showed a dose-response relation-
ship in urinary excretion of phloretin, measured after urine
hydrolysis, in 30 subjects supplemented for 4 weeks in a
cross-over design study with 40 g/d lyophilized apples of
two varieties differing in their polyphenol content [47].
Phloretin concentrations in 24 h urine were 0.78 ± 1.17
nmol/mg and 0.52 ± 0.68 nmol/mg creatinine after the high
and low polyphenol apples, respectively, which precisely
reflected the 1.5 ratio in phloretin content of the two apple
varieties. A dose-response relationship was also reported
by Saenger et al. [48] who involved 30 healthy volunteers
in an short-term parallel study with three doses of apples
(200, 400, and 790 g) consumed in a context of a freely
chosen background diet. Despite a high inter-individual
variation and a low number of subjects, the urine concen-
tration of phloretin quantified after urine hydrolysis was
significantly different after the low and medium dose
and after the high dose [48]. The kinetics study showed
that the phloretin was rapidly excreted, with a max-
imum at 3 ± 1 h, and that 24 h after the apple intake the
phloretin increase was no longer detectable [48].
The limited number of observational and human inter-
vention studies available suggests that urinary excretion
of phloretin and phloretin 2′-glucuronide are the most
promising candidate biomarkers of recent apple intake
[17, 41, 42]. According to an extensive search in the lit-
erature and online databases, no other significant dietary
sources of phloretin glycosides have been reported so
far. Strawberry can only be considered as a minor source
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its very low content [49]. The peel of immature kumquat
fruit contains a high amount of 3′,5′-Di-C-β-glucopyra-
nosylphloretin (up to 2 g per 100 g dry peel); however,
this fruit is barely consumed in most countries, and
therefore, the probability that it becomes a confounding
factor is rather low [50, 51]. In addition, of hundreds pa-
pers analyzing the composition to tomato, only four re-
ported a minor content of the di-C-hexoside 3′,5′-Di-
C-β-glucopyranosylphloretin in some varieties, and iden-
tification of the compound has never been confirmed by
analysis of an authentic standard [52–55]. To our know-
ledge, the presence of phloretin or phloretin glucuronide
was not detected so far in human or animal biofluids
after tomato intake. Furthermore, C-glycosides are much
less easily hydrolyzed than O-glycosides [56]; thus, it
seems unlikely that tomato could also constitute a con-
founder for phloretin as a biomarker of apple intake.
Phloretin and its glucuronide are also associated with
the intake of apple cider [26] and possibly other
apple-based foods such as applesauce and juice. Apple
processing for juice production has a major impact on
phloridizin and related compounds. The dihydrochal-
cones are mostly associated with the solid parts of the
fruit (peel and core zone) [57] and are poorly extracted
into the juice. They are prone to oxidation, especially
during the step of pulp enzyming when pectolytic en-
zymes are added to increase the juice extraction yield
[58]. Only 10–20% of the original dihydrochalcone con-
tent of the fruit is recovered in the apple juice [58, 59].
In addition, the importance of apple varieties will have
to be assessed, as the content in phloretin glycosides
may vary significantly. The concentration of phloridzin,
the main apple dihydrochalcone, has been recently
screened among 247 apple genotypes and has been to be
extremely variable within the Malus species, but rela-
tively stable within the 150 cultivated apple analyzed
(Malus x domestica) [60]. With the median concentra-
tion being 35.67 μg/g and with 75% of the 150 samples
investigated within 64.8 μg/g, these data are in good
agreement also with the total content on dihydrochal-
cones reported for the varieties most widely cultivated in
Europe [60]. Therefore, we can assume that the concen-
tration of apple dihydrochalcones is expected to have a
limited variability within the cultivated apples, with the
exception of the Renetta group (Renetta grigia, Renetta
Canada, and Renetta Canada bianca), having a much
higher concentration, up to a maximum of 310.6 μg/g
[61]. Similarly cider apple varieties are about four times
more concentrated than fresh consumed varieties [59],
which explains the higher urinary excretion of phloretin
observed after cider intake compared to apple juice in-
take [26, 44, 46]. But the latter, contrary to the Renetta
group, are usually not considered for fresh consumption.To be taken into consideration as well is the fact that
phloridzin is more concentrated in the skin, and thus,
the mode of apple consumption should be registered since
it may affect the relationship between the apple intake and
the urinary excretion of phloretin glucuronide [62].
Only little information on the bioavailability of apple
dihydrochalcones is available, obtained with low
-dimension studies (n = 6–30) reported in this review,
and possible inter-individual variation in the absorption
and metabolism of these compounds will have to be fur-
ther evaluated. Phloretin and phloretin glucuronide, be-
cause of their short half-life, belong to the short-term
biomarkers category and repeated measurement will be
necessary to assess the long-term consumption of apple.
For the same reason, measurement in morning spot
urine rather than in 24 h urine may less accurately reflect
the apple intake from the previous day. Methods based on
UPLC-MS/MS are available to quantify phloretin in hu-
man biofluids [63]. As phloretin 2′-glucuronide is largely
predominant in urine, either the glucuronide or the agly-
cone after urine hydrolysis may be quantified. However,
only the aglycone is commercially available as a standard.
To conclude, the urinary excretion of phloretin glucu-
ronide or of phloretin measured after sample hydrolysis
can be considered as the most promising specific bio-
marker of apple intake. The validation level of these can-
didate BFIs for apple is summarized in Fig. 2 which
shows the need for more validation studies. The time
window for urine collection and the dose-response rela-
tionships should notably be further documented. The
standardization of a method of analysis will have to be car-
ried out, which will include the conditions of the glucuro-
nide hydrolysis. As the phloretin precursors, phoridzin
and phloretin 2′-O-xyloglucoside, are expected to be
present in all the apple products, the question arises, as
for many other fruits, of the differentiation of the con-
sumption of apple as a fruit or as juice or cider. This ques-
tion is important as the categorization in food groups
differs for apple and apple products in epidemiological
studies and their health effects are likely to be divergent.
Pear biomarkers
Pear is a one of the oldest fruits cultivated in temperate
regions, and many cultivars are now available. According
to the comprehensive European food consumption data-
base, pear is the second most eaten pome fruit after
apple among the adult population, with a consumption
ranging from 23 to 108 g/day [16]. Pear is mainly con-
sumed fresh, but also canned and as juice. The available
knowledge of the composition of pear, as well as the two
studies performed by Nieman et al. [64] and Deisinger
et al. [65] (Table 1), suggest that arbutin (hydroquino-
ne-β-D-glucopyranoside) may be considered as a candi-
date biomarker of intake. Arbutin, along with other less
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acid, chlorogenic acid, rutin, and epicatechin, has been
consistently detected in different cultivars of pear [66].
Interestingly, arbutin is commonly used to detect the
adulteration of apple juices with pear in the food
industry [67]. The concentration of this glycosylated
hydroquinone ranges from 40 to 150 mg/l in pear juice
and 6–113mg/kg in fresh pear pulp [68]. Deisinger et al.
reported that from a range of foods, pear was the richest
source of arbutin with the skin reaching a concentration
40–60 times higher than the fruit’s flesh [65]. Fuentealba
and coworkers have recently reported the presence of
arbutin in walnuts of lighter color applying an untargeted
metabolomics approach with a GC-MS method [69]. Ore-
gano, marjoram, and wheat germ have also been reported
to contain a high amount of arbutin; however, their lower
level of consumption compared to pear does not make
them major confounders for most populations [65, 70].
By applying an untargeted metabolomics approach,
Nieman et al. [64] detected arbutin metabolites in hu-
man plasma samples after pear intake in a cross-over,
randomized, controlled trial. In this study, the authors
evaluated the effect of the intake of pear and banana on
the physical endurance and recovery of 20 male athletes
[64]. The results showed that arbutin and hydroquinone
sulfate were the most discriminant metabolites of pear
intake, along with various sugars, sugar acids (xylose,
fructose, arabonate/xylonate, ribitol, mannitol/sorbitol,
arabitol/xylitol), and some non-specific microbial metab-
olites of polyphenols (hippuric acid, 4-hydroxyhippurate,
dihydroferulic acid, 4-allylphenol sulfate, vanillic alcohol
sulfate, 3-(4-hydroxyphenyl)propionate). In the same
study, eugenol sulfate and 2-isopropylmalate were found
to increase after both pear and banana intake, opening
their consideration as possible markers of total fruit in-
take [64]. Eugenol is an allyl alkoxybenzene present in a
variety of food sources, such as spices, herbs, banana,
and orange, and has been recovered in glucuronidated
and sulfated form in healthy subjects [71].
2-Isopropylmalate was identified as one of the key pre-
cursors for aldehydes and alcohols that contribute to the
organoleptic properties of melon [72].
Deisinger et al. also reported the elevation of unidenti-
fied conjugated forms of hydroquinone in urine and
plasma samples of four volunteers after the consumption
of a hydroquinone and arbutin rich meal (784–1279 μg
total hydroquinone) [65]. Two hours after the meal con-
taining coffee, tea, wheat cereal, whole wheat bread,
wheat germ, and Bosc pears, volunteers exhibited a five-
fold elevation of hydroquinone in plasma (from 0.03 to
0.15 μg/g) while the urinary concentration of hydroquin-
one peaked 2–3 h after the meal (800 μg/h). The
pharmacokinetics of arbutin in humans was studied in a
randomized cross-over study in 16 healthy volunteerswho consumed extracts of bearberry leaves, a
non-dietary-rich source of arbutin [73]. About 65% of
the 210 mg of the arbutin ingested was excreted in urine
over a 24-h period, mostly in the first 4 h. Hydroquinone
glucuronide was the major metabolite, accounting for
70% of the total arbutin metabolites while hydroquinone
sulfate represented around 30%. Free hydroquinone was
minor and barely detected [73]. The usefulness of the
arbutin metabolite hydroquinone as a BFI of pear is
challenged by the fact that human exposure to this me-
tabolite is not limited to dietary sources. Environmental
exposures include smoking, contact with cosmetic for-
mulations such as nail polish and hair dyes, paint stabi-
lizers, motor fuels, and photographic agents [74–76].
Deisinger and coworkers reported that after volunteers
smoked four cigarettes in a 30-min period, plasma levels
of hydroquinone increased to a lesser extent than after a
hydroquinone-rich meal, from 0.015 to 0.030 μg/g within
10min, and then decreased [65]. The urinary excretion
of hydroquinone increased by a factor of 2.5 1 h after
smoking [65].
In conclusion, although arbutin is used as a marker in
the food industry to confirm the presence of pear in
food products, data supporting its possible usefulness as
BFI for pear are still scarce, as shown in Fig. 3. The find-
ings of Nieman et al. [64] show that arbutin as such, not
only its hydroquinone metabolites, is bioavailable after
the intake of pear. The latter opens the possibility of
using this compound as a marker of pear intake. In this
regard, the analysis of urine after the intake of the fruit
would offer an advantage over the study of plasma, as
performed on both studies reviewed in this section. The
analysis of urine generally allows a better insight of the
metabolic footprint of food intake. Dose-response rela-
tionship and inter-individual variation after pear intake
will have to be determined as these important validation
criteria for BFIs have not been studied at all for arbutin
excretion. The importance of confounding from dietary
and environmental sources also need to be carefully
assessed, in particular for use in large population studies.
Stone fruit biomarkers
Consumption of fresh cherry and other stone fruit is
globally lower than that of pome fruit and is typically
seasonal. For that reason, biomarkers of stone fruit in-
take may be mostly useful for monitoring compliance in
studies investigating their health effects rather than for
assessing the subjects’ adherence to a dietary pattern in
the long term. The cherry fruit is a nutrient dense food
containing a significant amount also of potentially bio-
active food components, including chlorogenic acid iso-
mers and anthocyanins [77]. As expected from the
phytochemical composition of cherry, cyanidin glyco-
sides were consistently found in plasma after cherry
Fig. 3 Overview of the validation process and its application process for candidate BFIs for pome fruits
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However, cyanidin glycosides are unlikely to serve as
biomarkers of cherry intake for various reasons, includ-
ing their chemical instability at neutral pH and their
non-specificity to cherry (Table 3). Anthocyanins are
also present in high content not only in a wide range of
berries such as blackberry and blackcurrant, but also in
grape, red onion, and red cabbage [81]. In fruit, anthocy-
anins usually exist as a complex mixture of conjugates
with various sugars, hydroxycinnamates, and organic
acids in proportions varying with the degree of fruit rip-
ening. Furthermore, the total content of anthocyanins is
increasing exponentially as the fruit ripens, which would
challenge the dose-response relationship. In addition,
cyanidin glycosides are detected in plasma for a very
brief period of time, typically 1–2 h after intake and their
concentration does not exceed a few dozens of nanomo-
lar even after an acute intake of several portions of ber-
ries [82]. In a randomized, double-blinded, cross-over
study on 12 healthy males, protocatechuic and vanillic
acids were shown to increase in plasma following the
intake of 30 or 60mL of Montmorency tart cherry
concentrate [83]. These phenolic acids are major metab-
olites of anthocyanins, such as cyanidin 3-glucoside, and
are thus likely to derive from cherry anthocyanin metab-
olism, which means that again these compounds are not
specific enough to cherry intake. The urinary excretion
of the melatonin metabolite 6-sulfatoxymelatonin can
increase (about 15–75%) after consumption of different
varieties of cherry [84, 85]. However, cherry consump-
tion cannot be considered as a major determinant of the
6-sulfatoxymelatonin plasma level, as it can originate
from both an endogenous synthesis and other richerdietary sources of melatonin [86, 87]. The same
conclusion applies for the urinary excretion of
5-hydroxyindoleacetic acid (5HIAA), which increased in
30 volunteers after consumption of cherries for 5 days
[88]. 5HIAA is the main metabolite of serotonin. In
humans, it can have an endogenous origin or derive
from the consumption of serotonin-rich foods such as
banana, pineapple, and walnut [89].
Other stone fruits for which a few relevant studies
were obtained with the systematic literature search are
plum and prune. Although their consumption is globally
quite low, plum, especially when provided as a juice, is
used as a functional food, mainly for its laxative effects
[90]. Some people may therefore have a high intake of
plum. As could be expected, some anthocyanins such as
peonidin 3-glucoside, peonidin 3-rutoside, and the me-
tabolites, cyanidin monoglucuronide and hippuric acid,
were reported in urine, in a pilot study with plum juice
[91], but as discussed above anthocyanins and their me-
tabolites do not deserve further attention as candidate
BFIs for any individual fruit. Caffeic acid was also detected
in plasma and urine after a single intake of 100 g prunes,
but this hydroxycinnamic acid is widely distributed in
plant foods with coffee as a major source [92]. The only
other metabolites reported so far as associated with plum
consumption are metabolites of 5-hydroxymethylfurfural
(HMF). In one study where plum was provided as juice,
5-hydroxymethyl-2-furoic acid (HMFA) and (5-carboxylic
acid-2-furoyl) glycine were detected in plasma and urine
[93]. HMF is formed from dehydration of fructose/glucose
and Maillard reaction during heat-treatments like drying
or cooking of sugar-containing foods. It has been identi-
fied in dried prunes and prune juice and in many
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mel, fruit juices, dried fruit, and honey and is also found
in cigarette smoke [94]. Although HMF metabolites may
have an interest when searching biomarkers of intake of
processed foods, they are not specific enough to be further
investigated as BFIs for plums.
In conclusion, almost everything remains to be done
in the field of intake biomarkers for stone fruit. Every
fruit has a specific phytochemical signature of hundreds
of compounds, and the exploration of this complexity
might reveal more specific candidate biomarkers among
the phytochemicals. Many of the fruit phytochemicals
have not been selected for targeted analyses so far since
they were not associated with an already known bio-
logical activity. However, databases containing informa-
tion on the phytochemical composition of foods, such as
FooDB, PhytoHub, Dr. Duke’s Phytochemical and
Ethnobotanical Databases, and CRC Dictionary of Food
Compounds, show the incredible diversity of compounds
in fruit, far beyond the most-studied polyphenols and ca-
rotenoids. In the particular case of stone fruit, these da-
tabases reveal specific phytochemicals, such as
cerasinone (7-hydroxy-2′,4′,5-trimethoxyflavanone) and
cerasin in sour cherry and ephedrannin A, syringetin
3-robinoside, and betuletol in apricot. After absorption
and metabolism, these species-specific phytochemicals
may lead to metabolites representing new candidate bio-
markers of stone fruit intake. Untargeted metabolomics
applied to intervention studies is of particular interest
for discovering such specific metabolites in a data-driven
approach, with a particular attention on trying to iden-
tify the expected metabolites of the specific phytochemi-
cals from different species of stone fruit.
General conclusion
The extensive literature search conducted under the
well-defined criteria of the BFIRev protocol demon-
strated the limited knowledge available so far regarding
the possible biomarkers of intake for pome and stone
fruit. Only urinary phloretin seems applicable for apple;
however, more validation work is needed before its level
can be translated into a value, or more likely a value
range, of apple consumption. The high interest raised re-
cently on the discovery of new biomarkers of food intake
and the development of good practices for using meta-
bolomics for that purpose will certainly lead to the pub-
lication of many new candidate biomarkers. The sharing
of metabolomics data acquired in independent observa-
tional and intervention studies will allow the rapid
examination of the specificity and other validation cri-
teria of the newly discovered biomarkers.
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